ArticleTherapeutic advances in medical oncology2019

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma.

Zhimin Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.